Effects of antipsychotic medication on functional connectivity in major depressive disorder with psychotic features

Marder SR, Cannon TD. Schizophrenia. N Engl J Med. 2019;381:1753–61.

Article  CAS  PubMed  Google Scholar 

Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry. 2012;73:486–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009;66:838–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Alexopoulos GS, Rudorfer MV, et al. Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial. JAMA. 2019;322:622–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho B-C, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128–37.

Article  PubMed  PubMed Central  Google Scholar 

Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, et al. A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia. JAMA Psychiatry. 2015;72:226–34.

Article  PubMed  PubMed Central  Google Scholar 

Szeszko PR, Robinson DG, Ikuta T, Peters BD, Gallego JA, Kane J, et al. White matter changes associated with antipsychotic treatment in first-episode psychosis. Neuropsychopharmacology. 2014;39:1324–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, et al. Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial. JAMA Psychiatry. 2020;77:674–83.

Article  PubMed  Google Scholar 

Konopaske GT, Dorph-Petersen K-A, Pierri JN, Wu Q, Sampson AR, Lewis DA. Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology. 2007;32:1216–23.

Article  CAS  PubMed  Google Scholar 

Konopaske GT, Dorph-Petersen K-A, Sweet RA, Pierri JN, Zhang W, Sampson AR, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry. 2008;63:759–65.

Article  CAS  PubMed  Google Scholar 

Vernon AC, Natesan S, Modo M, Kapur S. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry. 2011;69:936–44.

Article  CAS  PubMed  Google Scholar 

Vernon AC, Crum WR, Lerch JP, Chege W, Natesan S, Modo M, et al. Reduced Cortical Volume and Elevated Astrocyte Density in Rats Chronically Treated With Antipsychotic Drugs—Linking Magnetic Resonance Imaging Findings to Cellular Pathology. Biol Psychiatry. 2014;75:982–90.

Article  CAS  PubMed  Google Scholar 

Neufeld NH, Mulsant BH, Dickie EW, Meyers BS, Alexopoulos GS, Rothschild AJ, et al. Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study. EBioMedicine. 2018;36:446–53.

Article  PubMed  PubMed Central  Google Scholar 

Sudheimer K, Keller J, Gomez R, Tennakoon L, Reiss A, Garrett A, et al. Decreased hypothalamic functional connectivity with subgenual cortex in psychotic major depression. Neuropsychopharmacology. 2015;40:849–60.

Article  PubMed  Google Scholar 

Oudega ML, van der Werf YD, Dols A, Wattjes MP, Barkhof F, Bouckaert F, et al. Exploring resting state connectivity in patients with psychotic depression. PLoS One. 2019;14:e0209908.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2019;16:111–6.

Article  CAS  PubMed  Google Scholar 

Dickie EW, Anticevic A, Smith DE, Coalson TS, Manogaran M, Calarco N, et al. Ciftify: A framework for surface-based analysis of legacy MR acquisitions. Neuroimage. 2019;197:818–26.

Article  PubMed  Google Scholar 

Glasser MF, Coalson TS, Robinson EC, Hacker CD, Harwell J, Yacoub E, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536:171–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tian Y, Margulies DS, Breakspear M, Zalesky A. Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nat Neurosci. 2020;23:1421–32.

Article  CAS  PubMed  Google Scholar 

Ji JL, Spronk M, Kulkarni K, Repovš G, Anticevic A, Cole MW. Mapping the human brain’s cortical-subcortical functional network organization. Neuroimage. 2019;185:35–57.

Article  PubMed  Google Scholar 

R Core Team. R: A Language and Environment for Statistical Computing. 2021.

Bertolero MA, Yeo BTT, D’Esposito M. The modular and integrative functional architecture of the human brain. Proc Natl Acad Sci USA. 2015;112:E6798–E6807.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hugdahl K, Rund BR, Lund A, Asbjørnsen A, Egeland J, Ersland L, et al. Brain activation measured with fMRI during a mental arithmetic task in schizophrenia and major depression. Am J Psychiatry. 2004;161:286–93.

Article  PubMed  Google Scholar 

Del Fabro L, Delvecchio G, D’Agostino A, Brambilla P. Effects of olanzapine during cognitive and emotional processing in schizophrenia: A review of functional magnetic resonance imaging findings. Hum Psychopharmacol. 2019;34:e2693.

Article  PubMed  Google Scholar 

O’Donoghue B, Francey SM, Nelson B, Ratheesh A, Allott K, Graham J, et al. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants. Early Interv Psychiatry. 2019;13:953–60.

Article  PubMed  Google Scholar 

Chopra S, Fornito A, Francey SM, O’Donoghue B, Cropley V, Nelson B, et al. Differentiating the effect of antipsychotic medication and illness on brain volume reductions in first-episode psychosis: A Longitudinal, Randomised, Triple-blind, Placebo-controlled MRI Study. Neuropsychopharmacology. 2021;46:1494–501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chopra S, Francey SM, O’Donoghue B, Sabaroedin K, Arnatkeviciute A, Cropley V, et al. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2021;78:994–1004.

Article  PubMed  Google Scholar 

Veer IM, Beckmann CF, van Tol M-J, Ferrarini L, Milles J, Veltman DJ, et al. Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front Syst Neurosci. 2010;4:41.

Article  PubMed  PubMed Central  Google Scholar 

Yan C-G, Chen X, Li L, Castellanos FX, Bai T-J, Bo Q-J, et al. Reduced default mode network functional connectivity in patients with recurrent major depressive disorder. Proc Natl Acad Sci USA. 2019;116:9078–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javaheripour N, Li M, Chand T, Krug A, Kircher T, Dannlowski U, et al. Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium. Transl Psychiatry. 2021;11:511.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez A, Hillyard SA, Dias EC, Hagler DJ Jr, Butler PD, Guilfoyle DN, et al. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J Neurosci. 2008;28:7492–7500.

Article  PubMed  PubMed Central  Google Scholar 

Dias EC, Butler PD, Hoptman MJ, Javitt DC. Early Sensory Contributions to Contextual Encoding Deficits in Schizophrenia. Archives of General Psychiatry. 2011;68:654.

Article  PubMed  PubMed Central  Google Scholar 

McCleery A, Wynn JK, Lee J, Reavis EA, Ventura J, Subotnik KL, et al. Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia. Front Psychiatry. 2020;11:823.

Article  PubMed  PubMed Central  Google Scholar 

Schutte MJL, Bohlken MM, Collin G, Abramovic L, Boks MPM, Cahn W, et al. Functional connectome differences in individuals with hallucinations across the psychosis continuum. Sci Rep. 2021;11:1108.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang L-X, Guo F, Zhu Y-Q, Wang H-N, Liu W-M, Li C, et al. Effect of second-generation antipsychotics on brain network topology in first-episode schizophrenia: A longitudinal rs-fMRI study. Schizophr Res. 2019;208:160–6.

Article  PubMed 

留言 (0)

沒有登入
gif